Re: OVERALL AN EXCELLENT PRESENTATION AT R AND R TODAY SEPT 10, 2015
|
4
|
Resverlogix Corp.
|
Sep 14, 2015 11:45AM
|
Re: OVERALL AN EXCELLENT PRESENTATION AT R AND R TODAY SEPT 10, 2015
|
4
|
Resverlogix Corp.
|
Sep 11, 2015 09:11AM
|
Re: Patience
|
9
|
Resverlogix Corp.
|
Jan 17, 2022 09:26PM
|
Re: Patience
|
5
|
Resverlogix Corp.
|
Jan 18, 2022 09:17AM
|
Re: Pfizer to Acquire Medivation (Enzalutamide) for $14 B
|
2
|
Zenith Epigenetics
|
Aug 22, 2016 09:30PM
|
Re: Pilgrims Progress 2
|
3
|
Resverlogix Corp.
|
Jul 24, 2020 05:01PM
|
Re: Pitchforks
|
5
|
Resverlogix Corp.
|
Dec 19, 2020 11:17AM
|
Re: PNAS
|
7
|
Resverlogix Corp.
|
Jan 01, 2021 08:16PM
|
Re: PNAS
|
5
|
Resverlogix Corp.
|
Jan 01, 2021 08:20PM
|
Re: Potential funding for BETONMACE2 and Covid trial
|
7
|
Resverlogix Corp.
|
Oct 26, 2021 12:12AM
|
Re: Potential Suitor
|
9
|
Resverlogix Corp.
|
Sep 12, 2020 09:00PM
|
Re: Priceless on I.V. Regarding Zenith
|
5
|
Zenith Epigenetics
|
Apr 16, 2017 12:52AM
|
Re: Priceless on I.V. Regarding Zenith
|
3
|
Zenith Epigenetics
|
Apr 08, 2017 09:38PM
|
Re: Progress
|
3
|
Resverlogix Corp.
|
Jul 24, 2020 05:02PM
|
Re: Protecting shares from being borrowed by shorts
|
6
|
Resverlogix Corp.
|
May 18, 2018 11:54AM
|
Re: Protecting shares from being borrowed by shorts
|
2
|
Resverlogix Corp.
|
May 18, 2018 12:07PM
|
Re: Protecting shares from being borrowed by shorts
|
3
|
Resverlogix Corp.
|
May 18, 2018 12:19PM
|
Re: Protecting shares from being borrowed by shorts
|
2
|
Resverlogix Corp.
|
May 18, 2018 12:31PM
|
Re: Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 14, 2022 07:16PM
|
Re: Question about publications - Nature
|
2
|
Resverlogix Corp.
|
Feb 11, 2022 01:12PM
|